Gut bacteria booster may prevent deadly transplant complication
NCT ID NCT04373057
First seen Apr 22, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This study tests whether a dietary supplement called galacto-oligosaccharide (GOS) can prevent acute graft-versus-host disease (GVHD) in people receiving a stem cell transplant. The supplement aims to improve gut bacteria health, which may reduce the risk of GVHD. The trial involves 128 participants and will first find the best dose, then compare GOS to a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GVHD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke
ACTIVE_NOT_RECRUITINGDurham, North Carolina, 27710, United States
-
Kansas University Medical Center
RECRUITINGKansas City, Kansas, 66160, United States
Contact
Conditions
Explore the condition pages connected to this study.